Onderneming Viracta Therapeutics, Inc.
Aandelen
VIRX
US92765F1084
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8102 USD | -3,55% | -2,19% | +42,14% |
Vakgebied
Aantal werknemers: 40
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 62 | 19-09-22 |
Melody Burcar
DFI | Director of Finance/CFO | 41 | 01-09-22 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07-08-23 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06-07-21 |
Ivor Royston
BRD | Director/Board Member | 79 | 01-10-07 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01-10-21 |
Corporate Officer/Principal | - | 06-07-21 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06-07-21 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01-10-07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01-02-21 |
Barry Simon
BRD | Director/Board Member | 69 | 03-03-21 |
Mark Rothera
CEO | Chief Executive Officer | 62 | 19-09-22 |
Roger Pomerantz
CHM | Chairman | 67 | 01-06-20 |
Flavia Borellini
BRD | Director/Board Member | 65 | 14-08-21 |
Jane Barlow
BRD | Director/Board Member | 63 | 14-08-21 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03-03-21 |
Sam Murphy
BRD | Director/Board Member | - | 01-01-19 |
Jane Chung
BRD | Director/Board Member | 53 | 10-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 39 272 434 | 38 184 370 ( 97,23 %) | 0 | 97,20 % |
Aandeel B | 0 | 10 248 | 0 | 0 |
Bedrijfsgegevens
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,14% | 31,82 mln. | |
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers VIRX
- Onderneming Viracta Therapeutics, Inc.